Anthem Biosciences IPO Fully Subscribed on Day 2—Investor Appetite Signals Biotech Boom

Unknown Apr 02, 2026 550 Views

Anthem Biosciences’ blockbuster $395 million initial public offering (IPO) has been fully subscribed on the second day of bidding, underscoring strong investor confidence in India’s fastgrowing biotech sector. The Bengalurubased contract research and manufacturing firm is now poised t...